Psyence BioMed targets a Texas ibogaine trial with a US$5 million PsyLabs investment and a US$9 million share swap
Market Chameleon (Wed, 23-Sep 7:29 AM)
Psyence Biomedical Launches Texas Ibogaine Unit and Commits Up to US$5 Million in PsyLabs
at www.tipranks.com (Wed, 23-Sep 7:28 AM)